Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients
Pharmacogenomics and Personalized Medicine Aug 18, 2017
Salgado PC, et al. – The influence of the PPP3CA c.249G>A variant on the clinical outcomes of kidney transplant recipients, was examined. The clinical outcomes of Brazilian patients in the early phase of tacrolimus (TAC)–based immunosuppressive regimen were not impacted by the PPP3CA c.249G>A variant.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
